Cargando…

Targeting senescence to delay progression of multiple sclerosis

Multiple sclerosis (MS) is a chronic and often progressive, demyelinating disease of the central nervous system (CNS) white and gray matter and the single most common cause of disability in young adults. Age is one of the factors most strongly influencing the course of progression in MS. One of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oost, Wendy, Talma, Nynke, Meilof, Jan F., Laman, Jon D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208951/ https://www.ncbi.nlm.nih.gov/pubmed/30229272 http://dx.doi.org/10.1007/s00109-018-1686-x

Ejemplares similares

Multiple sclerosis and the microbiota: Progress in understanding the contribution of the gut microbiome to disease
por: Engelenburg, Hendrik J, et al.
Publicado: (2022)

Aging, Cellular Senescence, and Progressive Multiple Sclerosis
por: Papadopoulos, Dimitrios, et al.
Publicado: (2020)

Multiple sclerosis is linked to MAPK(ERK) overactivity in microglia
por: ten Bosch, George J. A., et al.
Publicado: (2021)

CD40 in Clinical Inflammation: From Multiple Sclerosis to Atherosclerosis
por: Laman, Jon D., et al.
Publicado: (1998)

A B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis Model
por: ’t Hart, Bert A., et al.
Publicado: (2017)

The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis
por: ‘T Hart, Bert A., et al.
Publicado: (2013)

Pathological ultrastructural alterations of myelinated axons in normal appearing white matter in progressive multiple sclerosis
por: Oost, Wendy, et al.
Publicado: (2023)

Selective Modulation of TNF–TNFRs Signaling: Insights for Multiple Sclerosis Treatment
por: Pegoretti, Valentina, et al.
Publicado: (2018)

Nutritional and ecological perspectives of the interrelationships between diet and the gut microbiome in multiple sclerosis: Insights from marmosets
por: Perez-Muñoz, Maria Elisa, et al.
Publicado: (2021)

Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis
por: Wiendl, Heinz, et al.
Publicado: (2015)

Modulation of Multiple Sclerosis and Its Animal Model Experimental Autoimmune Encephalomyelitis by Food and Gut Microbiota
por: van den Hoogen, Ward J., et al.
Publicado: (2017)

Confirmatory factor analysis of the Dutch Screening Visual Complaints questionnaire in people with multiple sclerosis
por: van der Feen, Fleur E., et al.
Publicado: (2022)

Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis
por: Nicaise, Alexandra M., et al.
Publicado: (2019)

Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis
por: Heidker, Rebecca M., et al.
Publicado: (2017)

Recent Progress in Multiple Sclerosis Treatment Using Immune Cells as Targets
por: Ma, Xiaohong, et al.
Publicado: (2023)

Objective perimetry and progression of multiple sclerosis
por: Maddess, Ted, et al.
Publicado: (2022)

Discrepant Effects of Human Interferon-gamma on Clinical and Immunological Disease Parameters in a Novel Marmoset Model for Multiple Sclerosis
por: Jagessar, S. Anwar, et al.
Publicado: (2011)

Intrathecal Inflammation in Progressive Multiple Sclerosis
por: Monaco, Salvatore, et al.
Publicado: (2020)

Diagnosis and Management of Progressive Multiple Sclerosis
por: Macaron, Gabrielle, et al.
Publicado: (2019)

Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics
por: Kamma, Emily, et al.
Publicado: (2022)

Autonomic Dysregulation, Cognitive Impairment, and Symptoms of Psychosis as an Unusual Presentation in an Anti-Aquaporin 4-Positive Patient
por: Ruiter, Annabel M., et al.
Publicado: (2017)

Secondary Progressive Multiple Sclerosis: New Insights
por: Cree, Bruce A.C., et al.
Publicado: (2021)

Significance of Mitochondrial Dysfunction in the Progression of Multiple Sclerosis
por: Blagov, Alexander V., et al.
Publicado: (2022)

Spinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria
por: Eckman, Emily, et al.
Publicado: (2021)

Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences
por: Uher, Tomas, et al.
Publicado: (2023)

Monitoring Progressive Multiple Sclerosis with Novel Imaging Techniques
por: Petracca, Maria, et al.
Publicado: (2018)

Understanding the Roles of the Kynurenine Pathway in Multiple Sclerosis Progression
por: Lim, Chai K., et al.
Publicado: (2010)

Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis
por: Correale, Jorge, et al.
Publicado: (2019)

Neurofilaments in progressive multiple sclerosis: a systematic review
por: Williams, Thomas, et al.
Publicado: (2020)

Novel Drugs in a Pipeline for Progressive Multiple Sclerosis
por: Sapko, Klaudia, et al.
Publicado: (2022)

Antibody Therapies for Progressive Multiple Sclerosis and for Promoting Repair
por: Havla, Joachim, et al.
Publicado: (2022)

Common Delayed Senescence of Melanocytes from Multiple Primary Melanoma Patients
por: Kohli, Jaskaren S., et al.
Publicado: (2017)

Senescent-like Blood Lymphocytes and Disease Progression in Amyotrophic Lateral Sclerosis
por: Yildiz, Ozlem, et al.
Publicado: (2022)

Characterization of Antigen-Induced CD4+ T-Cell Senescence in Multiple Sclerosis
por: Tomas-Ojer, Paula, et al.
Publicado: (2022)

MicroRNAs as disease progression biomarkers and therapeutic targets in experimental autoimmune encephalomyelitis model of multiple sclerosis
por: Martinez, Bridget, et al.
Publicado: (2020)

The Role of Astrocytes in Multiple Sclerosis Progression
por: Correale, Jorge, et al.
Publicado: (2015)

Potential Protective Role of Pregnancy and Breastfeeding in Delaying Onset Symptoms Related to Multiple Sclerosis
por: Logoteta, Alessandra, et al.
Publicado: (2023)

Progression in multiple sclerosis is associated with low endogenous NCAM
por: Gnanapavan, Sharmilee, et al.
Publicado: (2013)

Symptomatic Therapy and Rehabilitation in Primary Progressive Multiple Sclerosis
por: Khan, Fary, et al.
Publicado: (2011)

The effect of smoking on the symptoms and progression of multiple sclerosis: a review
por: Shirani, Afsaneh, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_sjlfn7tti5p8o2tbvf1m3o7e2t